Identification of BRCA1 and BRCA2 carriers by allele‐specific gene expression (AGE) analysis
- 6 February 2002
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 98 (5), 732-736
- https://doi.org/10.1002/ijc.10273
Abstract
Mutations in BRCA1 and BRCA2 genes confer a high risk of breast and ovarian cancer. As such, their identification is essential to reduce the risk of disease in healthy carriers, as well as in carriers who have already developed the disease because they are at increased risk for a second malignancy; moreover, noncarriers of BRCA1 and BRCA2 mutated families can be spared anxiety and unnecessary medical interventions. A number of problems, including large gene size, complex mutational spectra and genetic heterogeneity of the disease, however, make genetic testing labor intensive and often inconclusive. We devised a new mutation detection strategy called AGE (allele‐specific gene expression) analysis that relies on the detection of a “functional effect” of the mutation at the RNA level known as “nonsense‐mediated RNA decay,” thus avoiding several of the problems of BRCA1 and BRCA2 genetic testing. In particular, (i) AGE analysis discriminates among the predisposing genes and identifies mutation carriers with a single RT‐PCR reaction; (ii) it relies on the effect of truncating mutations, which represent the large majority of cases and thus identifies mutation carriers regardless of the specific genomic alteration; and (iii) it is specific for cis‐regulatory mutations that are missed at present by most of the methods. As AGE analysis has the potential to identify most of the BRCA1 and BRCA2 mutation carriers, it can be used as a preliminary screening method, thereby accelerating and increasing the sensitivity of the genetic testing process. Notably, other hereditary diseases whose genetic analysis is hampered by similar problems could benefit from this kind of approach.Keywords
This publication has 21 references indexed in Scilit:
- After BRCA1 and BRCA2—What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast CancerAmerican Journal of Human Genetics, 2001
- Hereditary breast cancer: a reviewSeminars in Cancer Biology, 2000
- Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer familiesOncogene, 1999
- Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer PatientsAmerican Journal of Human Genetics, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsNature Genetics, 1997
- Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysisNature Genetics, 1996
- Real time quantitative PCR.Genome Research, 1996
- Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populationsHuman Molecular Genetics, 1996
- Rapid detection of BRCA1 mutations by the protein truncation testNature Genetics, 1995